EIR Lantech Pharmaceuticals Mar 2019

Eric Dong FDA, Tenzin Jangchup FDA, Dipesh Shah FDA$595.00 - Available Now

FDA investigators audited the Lantech Pharmaceuticals - Chittivalasa, India facility and issued inspectional observation (via FDA 483) on 15 Mar 2019.

Product details

  • Category:
  • Inspection end: 15 Mar 2019
  • Location: Chittivalasa, India
  • FEI: 3012390454
Add To Cart